---
layout: default
---

# 1997-12-31 - IPO Alert: King Pharmaceutical available through Wit Capital

## Header Data

From: ian<span>@</span>witcapital.com<br>
To: cypherpunks@toad.com<br>
Message Hash: ba474be38db88fa99235761cc18cbed2829b8ff8863da4ecd1759cbed3332f1f<br>
Message ID: \<199712302358.PAA20038@toad.com\><br>
Reply To: _N/A_<br>
UTC Datetime: 1997-12-31 00:11:22 UTC<br>
Raw Date: Wed, 31 Dec 1997 08:11:22 +0800<br>

## Raw message

```
{% raw  %}From: ian@witcapital.com
Date: Wed, 31 Dec 1997 08:11:22 +0800
To: cypherpunks@toad.com
Subject: IPO Alert: King Pharmaceutical available through Wit Capital
Message-ID: <199712302358.PAA20038@toad.com>
MIME-Version: 1.0
Content-Type: text/plain




Wit Capital Corporation is pleased to announce that we are able to provide participation in the following public offering as described below:

Issuer: King Pharmaceutical, an integrated pharmaceutical company that manufactures, markets and sells branded and generic prescription pharmaceutical products.

Security:  Common Stock

Expected Size of Offering: 8,919,000 shares

Expected Price Range: $16.50 to $19.50 per share

Lead Underwriters: LEHMAN BROTHERS

If you think you may be interested in this Public Offering available through Wit Capital, please visit http://www.witcapital.com or call (888) 4-WIT-CAP.

You can view, print or download the Preliminary Prospectus from the New Issues section of our web site.  To purchase shares, you must first open an account, which you can do online.

Investing in public offerings is speculative, involves a high degree of risk and may not be appropriate for every investor.  As with all of your investments with Wit Capital, you must make your own determination of whether an investment in this offering is consistent with your investment objectives and risk tolerance.  To learn more about the risks of investing in public offerings please visit the New Issues section of our web site.

A REGISTRATION STATEMENT RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE 
SECURITIES AND EXCHANGE COMMISSION BUT HAS NOT YET BECOME EFFECTIVE.  THESE 
SECURITIES MAY NOT BE SOLD NOR MAY OFFERS TO BUY BE ACCEPTED PRIOR TO THE TIME 
THE REGISTRATION STATEMENT BECOMES EFFECTIVE.  THIS COMMUNICATION SHALL NOT 
CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY, NOR SHALL 
THERE BE ANY SALE OF THESE SECURITIES IN ANY JURISDICTION IN WHICH SUCH OFFER, 
SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION 
UNDER THE SECURITIES LAWS OF SUCH JURISDICTION.

NO OFFER TO BUY THE SECURITIES CAN BE ACCEPTED AND NO PART OF THE PURCHASE 
PRICE CAN BE RECEIVED UNTIL THE REGISTRATION STATEMENT BECOMES EFFECTIVE, AND 
ANY SUCH OFFER MAY BE WITHDRAWN AND REVOKED WITHOUT OBLIGATION OR 
COMMITMENT OF ANY KIND, AT ANY TIME PRIOR TO NOTICE OF ITS ACCEPTANCE GIVEN 
AFTER THE EFFECTIVE DATE.  AN INDICATION OF INTEREST IN RESPONSE TO THIS RESPONSE TO THIS ADVERTISEMENT WILL INVOLVE NO OBLIGATION OR COMMITMENT OF ANY KIND.

A broker dealer or its agent may only transact business in a state after licensure or satisfying qualification requirements of that state. If you reside in a particular state that Wit Capital is not registered in as a 
broker dealer or has registered agents in, this message is not directed to you. Wit Capital will not open a brokerage account or sell securities to you until such time registration requirements in your home state are fulfilled.  Thank you.

Wit Capital Corporation
Member NASD/SIPC






{% endraw %}
```

## Thread

+ Return to [December 1997](/archive/1997/12)

+ Return to "[ian<span>@</span>witcapital.com](/authors/ian_at_witcapital_com)"

+ 1997-12-31 (Wed, 31 Dec 1997 08:11:22 +0800) - IPO Alert: King Pharmaceutical available through Wit Capital - _ian@witcapital.com_

